ArticleOral oncology2021

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101.

Michael J Jelinek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.